These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33724143)

  • 1. Assessment of cystatin C in pediatric sickle cell disease and β-thalassemia as a marker of subclinical cardiovascular dysfunction: a case-control study.
    Hanna D; Beshir M; Khalifa N; Baz E; Elhewala A
    Pediatr Hematol Oncol; 2021 Oct; 38(7):620-632. PubMed ID: 33724143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Predictive Value of Cystatin C in Pediatric Sickle Cell Disease: A Marker of Disease Severity and Subclinical Cardiovascular Dysfunction.
    Tantawy AAG; Adly AAM; Ismail EAR; Abdelazeem M
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):1010-1017. PubMed ID: 27582023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-2 as a Marker of Retinopathy in Children and Adolescents With Sickle Cell Disease: Relation to Subclinical Atherosclerosis.
    Andrawes NG; Ismail EA; Roshdy MM; Ebeid FSE; Eissa DS; Ibrahim AM
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):361-370. PubMed ID: 30994508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker.
    Sherief LM; Dawood O; Ali A; Sherbiny HS; Kamal NM; Elshanshory M; Alazez OA; Alhady MA; Nour M; Mokhtar WA
    BMC Pediatr; 2017 Mar; 17(1):69. PubMed ID: 28279156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C, Beta2 Microglobulin, N-Acetyl-beta-D-glucosaminidase, Retinol-Binding Protein, and Endothelin 1 Levels in the Evaluation of Sickle Cell Disease Nephropathy.
    Unal S; Kotan C; Delibas A; Oztas Y
    Pediatr Hematol Oncol; 2015 May; 32(4):250-7. PubMed ID: 23987825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia.
    Voskaridou E; Terpos E; Michail S; Hantzi E; Anagnostopoulos A; Margeli A; Simirloglou D; Loukopoulos D; Papassotiriou I
    Kidney Int; 2006 Jun; 69(11):2037-42. PubMed ID: 16501491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma chitotriosidase and carotid intima-media thickness in children with sickle cell disease.
    Kaddah NA; Saied DA; Alwakeel HA; Hashem RH; Rowizak SM; Elmonem MA
    Int J Hematol; 2017 Nov; 106(5):648-654. PubMed ID: 28677113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.
    Adly AAM; ElSherif NHK; Ismail EAR; Ibrahim YA; Niazi G; Elmetwally SH
    Redox Rep; 2017 Nov; 22(6):430-438. PubMed ID: 28288539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Structural and Functional Changes in Children With β-Thalassemia and Sickle Cell Disease: Relationship to Sleep-disordered Breathing.
    Elalfy MS; Youssef OI; Deghedy MMR; Abdel Naby MM
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):171-177. PubMed ID: 29494380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Transforming Growth Factor β-1 as a Marker of Renal Dysfunction in Sickle Cell Disease.
    Ghobrial EE; Abdel-Aziz HA; Kaddah AM; Mubarak NA
    Pediatr Neonatol; 2016 Jun; 57(3):174-80. PubMed ID: 26508723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Renal Insufficiency in a Cohort of Patients With Beta-thalassemia Major Using Cystatin-C.
    Hamdy M; Shaheen I; El-Gammal ZM; Ramadan YM
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1082-e1087. PubMed ID: 33843816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease.
    Adly AA; Ismail EA; Andrawes NG; Mahmoud MM; Eladawy R
    Cytokine; 2016 Mar; 79():52-8. PubMed ID: 26765484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent associations of urinary albumin-to-creatinine ratio and serum cystatin C with carotid intima-media thickness in community-living Taiwanese adults.
    Liu CS; Li CI; Guo YC; Lin CH; Lin WY; Liu CH; Wang MC; Yang CW; Yang SY; Li TC; Lin CC
    BMC Nephrol; 2020 Oct; 21(1):454. PubMed ID: 33129312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
    Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
    Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Predictors of Renal Dysfunction in Pediatric Patients with Sickle Cell Disease.
    El-Gamasy MA; El-Naghy WS
    Indian J Nephrol; 2019; 29(1):28-33. PubMed ID: 30814790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor-15 in children and adolescents with thalassemia intermedia: Relation to subclinical atherosclerosis and pulmonary vasculopathy.
    Tantawy AA; Adly AA; Ismail EA; Youssef OI; Ali ME
    Blood Cells Mol Dis; 2015 Aug; 55(2):144-50. PubMed ID: 26142330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical atherosclerotic predictive value of inflammatory markers in thalassemia intermedia patients.
    Ahmad Ibrahim O; Ahmad AB; Nigm DA; Hussien AN; Mohammad Ibrahim WH
    Expert Rev Hematol; 2021 Jul; 14(7):669-677. PubMed ID: 34296962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between serum cystatin C and carotid intima-media thickness in metabolic syndrome patients with normal estimated glomerular filtration rate.
    Huang R; Gu J; Cao Q; Ma J; Gu W; Fan Z
    Clin Chim Acta; 2015 Aug; 448():170-3. PubMed ID: 26164387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.